Skip to main content

A Low Cost, Environmentally, Friendly Smart Packaging Technology to Differentiate European SME Suppliers to Service the Needs of the Blind, Illiterate and Europe's Aging Population.

Objective

Printed instructions are meaningless to around 20% of the European Population. This figure, combined with the 8million registered blind and partially sighted as well as the ever increasing aging population are contributing to the 194,500 deaths a year in the EU due to miss-dose and non-compliance of prescribed medication. Non-compliance is estimated to cost the European Union 125bn euros annually, of which 2.25bn euros is annually paid by Europe's struggling SME pharmacist community. Our idea is to take current state-of-the-art compliance monitoring, enhance it and combine it with our speech technology incorporating them into Pharmaceutical blister packaging through novel manufacturing techniques such as In-mould labelling, over moulding and encapsulation. These technologies will overcome the problems associated with non-compliance and miss-dose, specifically through the incorporation of Spoken instructions. Further more, the primary objective of the project is to develop an eco-friendly power generation system that will harness 'free' solar energy through the incorporation of thin film, flexible, photovoltaic laminates, with specific innovation being in the homogenisation of the photovoltaic and the polymer packaging through in-mould labelling techniques. The speech system and compliance electronics will be developed onto a flexible PCB which will be over-moulded enabling incorporation into the packaging ensuring that the instructions are never lost from the medication. The spoken instructions will be heard through a piezo-electric sounder that will be encapsulated into the polymer packaging during the injection moulding process. Dosage assurance will be achieved through the printing of conductive ink electrodes onto the blister sealing film that will input to the compliance circuitry. The technical risks are high, but justified by the huge economic, social and environmental benefits, and are addressed through a methodical and structured program of work.

Call for proposal

FP6-2003-SME-1
See other projects for this call

Coordinator

MEGAVOICE IRELAND LTD
Address
Slieve Gallion, 8A Drumullan Road, Moneymore
Co Londonderry, Northern Ireland
United Kingdom

Participants (10)

A K INDUSTRIES LIMITED
United Kingdom
Address
Foxwood Court Rotherwas
Hereford
CENTRE DE RECERCA I INVESTIGACIO DE CATALUNYA S A
Spain
Address
C/margallo 12
Barcelona
FAROMED H.GES.M.B.H
Austria
Address
Johann Strausse-gasse 7/5
Vienna
IT MOBILE OY
Finland
Address
Linnaisten Kartano, Ainontie 33
Vantaa
MTC HOLDING GMBH
Austria
Address
Graf Starhemberggasse 37 / 7
Wien
MTC POLSKA SP.Z.O.O
Poland
Address
Ul Traktowa 4
Pruszkow
NOVARTIS PHARMA AG
Switzerland
Address
Lichtstrasse 35
Basel
PERA INNOVATION LIMITED
United Kingdom
Address
Pera Innovation Park, Nottingham Road
Melton Mowbray, Leicestershire
ROYAL NATIONAL INSTITUTE OF THE BLIND
United Kingdom
Address
105 Judd Street
WC1H 9NE London
UNIA FARMACEUTOW - WLASCICIELI APTEK
Poland
Address
Ul. Klonowa 6
Warszawa